04.25.12
A meta-analysis published online April 9 by the Archives of Internal Medicine has been panned as “limited” and “inaccurate” by industry trade associations. The study, titled “Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease” suggested there is insufficient evidence to prove that omega 3 fatty acid supplements offer secondary prevention of cardiovascular events in patients with heart disease. The Natural Products Association (NPA) , Washington D.C., and the Council for Responsible Nutrition (CRN),Washington D.C., and The Global Organization for EPA & DHA Omega-3s (GOED), Salt Lake City, UT, each took issue with the study.